SCHEMBL7086909

SCHEMBL7086909

COC(=O)C=Cc1cccc(Oc2ccccc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.66
PTGS1 P23219 2/20 0.66
PTGS2 P35354 2/20 0.66
BACE1 P56817 1/20 0.62
KDM5A P29375 1/20 0.58
BCHE P06276 1/20 0.57
MAPT P10636 1/20 0.56
MEN1 O00255 2/20 0.55
POLB P06746 2/20 0.55
KMT2A Q03164 2/20 0.55
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
ALOX5AP P20292 1/20 0.54
FOS P01100 1/20 0.54
JUN P05412 1/20 0.54
EPOR P19235 2/20 0.53
TTR P02766 1/20 0.53
APP P05067 1/20 0.53
TLR4 O00206 1/20 0.52
TLR2 O60603 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7086903 1.00 ALOX5 (0.66) ALOX5PTGS1PTGS2BACE1KDM5A
SCHEMBL9380189 0.90 CA12 (0.60) ALOX5PTGS1PTGS2BACE1KDM5A
SCHEMBL7091399 0.90 P2RX3 (0.57) ALOX5PTGS1PTGS2BACE1KDM5A
SCHEMBL7091402 0.90 P2RX3 (0.57) ALOX5PTGS1PTGS2BACE1KDM5A
SCHEMBL9380196 0.90 CA12 (0.60) ALOX5PTGS1PTGS2BACE1KDM5A
SCHEMBL3290633 0.86 MAOB (0.66) BCHEMAPTMEN1KMT2ANPC1
SCHEMBL30970401 0.86 MAOB (0.66) BCHEMAPTMEN1KMT2ANPC1
SCHEMBL2774221 0.86 KMT2A (0.65) BCHEMAPTMEN1KMT2ANPC1
SCHEMBL31737429 0.86 MAOB (0.66) BCHEMAPTMEN1KMT2ANPC1
SCHEMBL3290630 0.86 MAOB (0.66) BCHEMAPTMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115003704-A Polymeric composition having excellent storage stability, encapsulating material and display device 可隆工业株式会社 2022-09-02 CN disclosed
EP-3145935-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS DAG-LIPASE INHIBITORS Universiteit Leiden (NL) 2017-03-29 EP disclosed
WO-2016188972-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS DAG-LIPASE INHIBITORS UNIVERSITEIT LEIDEN (NL) 2016-12-01 WO disclosed
EP-3095787-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS DAG-LIPASE INHIBITORS Universiteit Leiden (NL) 2016-11-23 EP disclosed
US-20030194375-A1 Administering 3-aminopropionic acid derivative as anticonvulsant QUEEN'S UNIVERSITY AT KINGSTON AND NEUROCHEM, INC. 2003-10-16 US disclosed
EP-0363782-B1 Aryloxy-, arylthio-, heteroaryloxy-, heteroarylthio-alkenylene derivatives of amines ERBA CARLO SPA (IT) 1994-01-05 EP disclosed
US-5272144-A Aryloxy-, arylthio-, heteroaryloxy-, heteroarylthio-alkenylene derivatives of amines and pharmaceutical use FARMITALIA CARLO ERBA S.R.L. (IT) 1993-12-21 US disclosed
EP-0240121-B1 DIPHENYL ETHER DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-04-17 EP disclosed
EP-0390228-A2 Chemical intermediates IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-10-03 EP disclosed
EP-0363782-A1 Aryloxy-, arylthio-, heteroaryloxy-, heteroarylthio-alkenylene derivatives of amines FARMITALIA CARLO ERBA S.r.l. (IT) 1990-04-18 EP disclosed
US-4791139-A Diphenyl ether derivatives and their use as insecticides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-12-13 US disclosed
EP-0240121-A2 Diphenyl ether derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030194375-A1 Administering 3-aminopropionic acid derivative as anticonvulsant SLC1A2, SLC1A1, SLC1A3 ALOX5 314/4885PTGS1 662/4885PTGS2 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.